» Articles » PMID: 10602325

Activation of Muscle Nicotinic Acetylcholine Receptor Channels by Nicotinic and Muscarinic Agonists

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1999 Dec 22
PMID 10602325
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

1. The dose-response parameters of recombinant mouse adult neuromuscular acetylcholine receptor channels (nAChR) activated by carbamylcholine, nicotine, muscarine and oxotremorine were measured. Rate constants for agonist association and dissociation, and channel opening and closing, were estimated from single-channel kinetic analysis. 2. The dissociation equilibrium constants were (mM): ACh (0. 16)<oxotremorine M (0.6)<carbamylcholine (0.8)<nicotine (2.6). 3. The gating equilibrium constants (opening/closing) were: ACh (45)>carbamylcholine (5.1)>oxotremorine M (0.6)>nicotine (0. 5)>muscarine (0.15). 4. Rat neuronal alpha4beta2 nAChR can be activated by all of the agonists. However, detailed kinetic analysis was impossible because the recordings lacked clusters representing the activity of a single receptor complex. Thus, the number of channels in the patch was unknown and the activation rate constants could not be determined. 5. Considering both receptor affinity and agonist efficacy, muscarine and oxotremorine are significant agonists of muscle-type nAChR. The results are discussed in terms of structure-function relationships at the nAChR transmitter binding site.

Citing Articles

Lateral axonal modulation is required for stimulus-specific olfactory conditioning in Drosophila.

Manoim J, Davidson A, Weiss S, Hige T, Parnas M Curr Biol. 2022; 32(20):4438-4450.e5.

PMID: 36130601 PMC: 9613607. DOI: 10.1016/j.cub.2022.09.007.


Neuroprotective and Antioxidant Role of Oxotremorine-M, a Non-selective Muscarinic Acetylcholine Receptors Agonist, in a Cellular Model of Alzheimer Disease.

Nuzzo D, Frinchi M, Giardina C, Scordino M, Zuccarini M, De Simone C Cell Mol Neurobiol. 2022; 43(5):1941-1956.

PMID: 36056992 PMC: 10287780. DOI: 10.1007/s10571-022-01274-9.


Nicotinic cholinergic system and COVID-19: evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions.

Alexandris N, Lagoumintzis G, Chasapis C, Leonidas D, Papadopoulos G, Tzartos S Toxicol Rep. 2021; 8:73-83.

PMID: 33425684 PMC: 7776751. DOI: 10.1016/j.toxrep.2020.12.013.


Investigating the function and possible biological role of an acetylcholine-gated chloride channel subunit (ACC-1) from the parasitic nematode Haemonchus contortus.

Callanan M, Habibi S, Law W, Nazareth K, Komuniecki R, Forrester S Int J Parasitol Drugs Drug Resist. 2018; 8(3):526-533.

PMID: 30401619 PMC: 6287539. DOI: 10.1016/j.ijpddr.2018.10.010.


Cholinergic Overstimulation Attenuates Rule Selectivity in Macaque Prefrontal Cortex.

Major A, Vijayraghavan S, Everling S J Neurosci. 2017; 38(5):1137-1150.

PMID: 29255006 PMC: 6596265. DOI: 10.1523/JNEUROSCI.3198-17.2017.


References
1.
Wang H, Auerbach A, Bren N, Ohno K, Engel A, Sine S . Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. J Gen Physiol. 1997; 109(6):757-66. PMC: 2217038. DOI: 10.1085/jgp.109.6.757. View

2.
Mulle C, Changeux J . A novel type of nicotinic receptor in the rat central nervous system characterized by patch-clamp techniques. J Neurosci. 1990; 10(1):169-75. PMC: 6570336. View

3.
Qin F, Auerbach A, Sachs F . Estimating single-channel kinetic parameters from idealized patch-clamp data containing missed events. Biophys J. 1996; 70(1):264-80. PMC: 1224925. DOI: 10.1016/S0006-3495(96)79568-1. View

4.
Akk G, Sine S, Auerbach A . Binding sites contribute unequally to the gating of mouse nicotinic alpha D200N acetylcholine receptors. J Physiol. 1996; 496 ( Pt 1):185-96. PMC: 1160835. DOI: 10.1113/jphysiol.1996.sp021676. View

5.
Akk G, Zhou M, Auerbach A . A mutational analysis of the acetylcholine receptor channel transmitter binding site. Biophys J. 1999; 76(1 Pt 1):207-18. PMC: 1302512. DOI: 10.1016/S0006-3495(99)77190-0. View